Lynch Syndrome Detection Bundle:
This genetic testing bundle identifies mutations in MLH1, MSH2, MSH6, PMS2, and EPCAM genes linked to Lynch syndrome, a hereditary condition elevating risks for colorectal, endometrial, and ovarian cancers. Using next-generation sequencing (NGS), the panel offers precise detection of pathogenic variants. Designed for early intervention, the service enhances cancer prevention through proactive, accessible hereditary cancer care.
(This care bundle aligns with NICE guidance)
